HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CYTK
Cytokinetics Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $7.75B
Market Cap
$7.75B
Enterprise Val
$8.15B
P/E Ratio
-9.87
P/B Ratio
-11.74
Trailing PEG (1Y)
-0.52
As Of
Apr 30, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$659.6M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity172.91%
Return on Assets-58.68%
Current Ratio4.53
Debt/Equity-1.95
LT Debt/Equity-1.86
Revenue Per Share0.15

Income Statement

Dec 31, 2025
Revenue$17.8M
Cost of Revenue$0.00
Gross Profit$17.8M
R&D$104.4M
SG&A$91.7M
Operating Expenses$196.1M
Operating Income-$178.4M
Interest Expense$14.3M
Tax Expense$0.00
Net Income-$183.0M
EPS (Basic)$-1.50
EPS (Diluted)$-1.50
EBIT-$168.8M
EBITDA-$165.9M
Consolidated Income-$183.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$122.5M
Accounts Receivable$17.8M
Inventory$0.00
Current Assets$917.0M
LT Investments$335.0M
Property, Plant & Equipment$155.2M
Intangibles$0.00
Non-Current Assets$507.6M
Total Assets$1.42B
Accounts Payable$22.3M
Current Debt$60.3M
Current Liabilities$202.5M
LT Debt$1.22B
Non-Current Liabilities$1.88B
Total Liabilities$2.08B
Total Debt$1.28B
Retained Earnings-$3.49B
Shareholder Equity-$659.6M
Shares Outstanding122,264,929

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$142.7M
Investing Cash Flow-$71.2M
Financing Cash Flow$110.7M
CapEx-$5.6M
Free Cash Flow-$148.3M
Depreciation & Amort.$2.9M
Stock-Based Comp$30.5M
Acquisitions / Disposals$0.00
Investment Activity-$65.5M
Debt Issued/Repaid$172.3M
Equity Issued/Repaid$14.6M
Dividends Paid$0.00
Net Change in Cash-$102.9M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h